138 related articles for article (PubMed ID: 1691921)
41. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study.
Zatloukal P; Petruzelka L; Zemanova M; Havel L; Janku F; Judas L; Kubik A; Krepela E; Fiala P; Pecen L
Lung Cancer; 2004 Oct; 46(1):87-98. PubMed ID: 15364136
[TBL] [Abstract][Full Text] [Related]
42. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Furuse K; Fukuoka M; Kawahara M; Nishikawa H; Takada Y; Kudoh S; Katagami N; Ariyoshi Y
J Clin Oncol; 1999 Sep; 17(9):2692-9. PubMed ID: 10561343
[TBL] [Abstract][Full Text] [Related]
43. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer.
Imaizumi M;
Lung Cancer; 2005 Jul; 49(1):85-94. PubMed ID: 15949594
[TBL] [Abstract][Full Text] [Related]
44. The role of vindesine and lonidamine in the treatment of elderly patients with advanced non-small cell lung cancer: a phase III randomized FONICAP trial. Italian Lung Cancer Task Force.
De Marinis F; Rinaldi M; Ardizzoni A; Bruzzi P; Pennucci MC; Portalone L; D'Aprile M; Ripanti P; Romano F; Belli M; Altavilla G; Migliorino MR; Rosso R; Salvati F
Tumori; 1999; 85(3):177-82. PubMed ID: 10426128
[TBL] [Abstract][Full Text] [Related]
45. Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.
Ramlau R; Zatloukal P; Jassem J; Schwarzenberger P; Orlov SV; Gottfried M; Pereira JR; Temperley G; Negro-Vilar R; Rahal S; Zhang JK; Negro-Vilar A; Dziewanowska ZE
J Clin Oncol; 2008 Apr; 26(11):1886-92. PubMed ID: 18398154
[TBL] [Abstract][Full Text] [Related]
46. Economic evaluation of a randomized clinical trial comparing vinorelbine, vinorelbine plus cisplatin, and vindesine plus cisplatin for non-small-cell lung cancer.
Smith TJ; Hillner BE; Neighbors DM; McSorley PA; Le Chevalier T
J Clin Oncol; 1995 Sep; 13(9):2166-73. PubMed ID: 7666075
[TBL] [Abstract][Full Text] [Related]
47. Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer.
Ellis PA; Smith IE; Hardy JR; Nicolson MC; Talbot DC; Ashley SE; Priest K
Br J Cancer; 1995 Feb; 71(2):366-70. PubMed ID: 7530988
[TBL] [Abstract][Full Text] [Related]
48. Cisplatin-cyclophosphamide-mitomycin combination chemotherapy with supportive care versus supportive care alone for treatment of metastatic non-small-cell lung cancer.
Cartei G; Cartei F; Cantone A; Causarano D; Genco G; Tobaldin A; Interlandi G; Giraldi T
J Natl Cancer Inst; 1993 May; 85(10):794-800. PubMed ID: 8387607
[TBL] [Abstract][Full Text] [Related]
49. Cisplatin and vindesine for disseminated non-small cell lung cancer. Results of a prospective trial with 81 patients.
Tourani JM; Penaud D; Caubarrere I; Darse J; Balzon JC; Boita F; Lebas FX; Lafitte JJ; Andrieu JM
Bull Cancer; 1990; 77(11):1107-13. PubMed ID: 2177357
[TBL] [Abstract][Full Text] [Related]
50. Gefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR-mutation-positive non-small-cell lung cancer after progression on first-line gefitinib (IMPRESS): a phase 3 randomised trial.
Soria JC; Wu YL; Nakagawa K; Kim SW; Yang JJ; Ahn MJ; Wang J; Yang JC; Lu Y; Atagi S; Ponce S; Lee DH; Liu Y; Yoh K; Zhou JY; Shi X; Webster A; Jiang H; Mok TS
Lancet Oncol; 2015 Aug; 16(8):990-8. PubMed ID: 26159065
[TBL] [Abstract][Full Text] [Related]
51. Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC): a FONICAP randomized phase II study. Italian Lung Cancer Task Force (FONICAP).
Baldini E; Tibaldi C; Ardizzoni A; Salvati F; Antilli A; Portalone L; Barbera S; Romano F; De Marinis F; Migliorino MR; Noseda MA; Borghini U; Crippa M; Ferrara G; Raimondi M; Fioretti M; Bandera M; Pennucci MC; Galeasso G; Cacciani GC; Lepidini G; Sunseri G; Lanfranco C; Rinaldi M; Rosso R
Br J Cancer; 1998 Jun; 77(12):2367-70. PubMed ID: 9649160
[TBL] [Abstract][Full Text] [Related]
52. [Is chemotherapy with cisplatin useful in non small cell bronchial cancer at staging IV? Results of a randomized study].
Quoix E; Dietemann A; Charbonneau J; Boutin C; Meurice JC; Orlando JP; Ducolone A; Pauli G; Roegel E
Bull Cancer; 1991; 78(4):341-6. PubMed ID: 1650266
[TBL] [Abstract][Full Text] [Related]
53. Combined chemotherapy and differentiation therapy in the treatment of advanced non-small-cell lung cancer.
Recchia F; Sica G; De Filippis S; Rea S; Frati L
Anticancer Res; 1997; 17(5B):3761-5. PubMed ID: 9427776
[TBL] [Abstract][Full Text] [Related]
54. Role of vindesine in induction chemotherapy in locally-advanced non-small-cell lung cancer.
Fischer JR; Drings P
J Cancer Res Clin Oncol; 1998 Jan; 124(1):4-9. PubMed ID: 9498828
[TBL] [Abstract][Full Text] [Related]
55. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.
Dillman RO; Herndon J; Seagren SL; Eaton WL; Green MR
J Natl Cancer Inst; 1996 Sep; 88(17):1210-5. PubMed ID: 8780630
[TBL] [Abstract][Full Text] [Related]
56. [Randomized trial of cisplatin plus ifosfamide versus cisplatin plus vindesine for non-small cell lung cancer (NSCLC)].
Nakabayashi T; Miyamoto H; Fujikane T; Shimizu T; Yasuda S; Akita H; Sakai E; Onodera S; Ohsaki Y; Kawakami Y
Gan To Kagaku Ryoho; 1992 Jan; 19(1):61-7. PubMed ID: 1309633
[TBL] [Abstract][Full Text] [Related]
57. Vindesine, cisplatin, and bleomycin combination chemotherapy in non-small cell lung cancer: survival and quality of life.
Bakker W; van Oosterom AT; Aaronson NK; van Breukelen FJ; Bins MC; Hermans J
Eur J Cancer Clin Oncol; 1986 Aug; 22(8):963-70. PubMed ID: 2429843
[TBL] [Abstract][Full Text] [Related]
58. Two cycles of cisplatin-vindesine and radiotherapy for localized nonsmall cell carcinoma of the lung (stage III). Results of a prospective trial with 149 patients.
Tourani JM; Timsit JF; Delaisement C; Balzon JC; Caubarrere I; Darse J; Geraads A; Lebas FX; Andrieu JM
Cancer; 1990 Apr; 65(7):1472-7. PubMed ID: 2155697
[TBL] [Abstract][Full Text] [Related]
59. Is there a role for vindesine in the treatment of non-small cell lung cancer?
Sørensen JB; Hansen HH
Invest New Drugs; 1993; 11(2-3):103-33. PubMed ID: 8262725
[TBL] [Abstract][Full Text] [Related]
60. Randomised trial of vindesine and etoposide +/- dexverapamil in advanced non-small cell lung cancer: first results.
Gatzemeier U; Schneider A; von Pawel J
J Cancer Res Clin Oncol; 1995; 121 Suppl 3():R17-20. PubMed ID: 8698737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
